Li Song Teng


Affiliation: Zhejiang University
Country: China


  1. Jiang X, Wu M, Xu Z, Wang H, Wang H, Yu X, et al. HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer. Cancer Manag Res. 2018;10:6857-6867 pubmed publisher
    ..Our findings highlight that HJC0152 is a promising therapeutic agent for GC. ..
  2. Su X, Chen S, He K, Mao Z, Ruan J, Zhou J, et al. Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerization. Endocrine. 2019;: pubmed publisher
    ..The present study confirms "field cancerization" in early-stage bilateral thyroid cancers, suggesting that these subtype papillary thyroid cancers should be treated as independent and localized tumors. ..
  3. Gu Y, Chen T, Fu S, Sun X, Wang L, Wang J, et al. Perioperative dynamics and significance of amino acid profiles in patients with cancer. J Transl Med. 2015;13:35 pubmed publisher
    ..Tumor-related amino acids identified by dynamic study of PFAA patterns may have the potential to be developed as novel biomarkers for diagnosis and prognosis of cancer patients. ..
  4. Wang H, Zhang X, Teng L, Legerski R. DNA damage checkpoint recovery and cancer development. Exp Cell Res. 2015;334:350-8 pubmed publisher
    ..This review also provides insight into the mechanism by which the DDR suppresses oncogene-driven tumorigenesis and tumor progression. ..
  5. request reprint
    Zhang H, Zhang J, Wang H, Su X, Teng L. Impact of Omega-3 Fatty Acid Supplements on Gastrointestinal Cancer Patients after Surgery: Beneficial or Useless?. Asian Pac J Cancer Prev. 2015;16:6841-3 pubmed
    ..This paper reviews recent research to establish therapeutic effects as well as possible underlying mechanisms of ????PUFA actions, and to help explain possible reasons for inconsistent results from different institutions. ..
  6. Ma W, Wang H, Teng L. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. World J Surg Oncol. 2013;11:212 pubmed publisher
    ..While HCC patients with serum AFP higher than 20 ng/mL need comprehensive therapy besides surgical resection and close follow up. ..
  7. Su X, Wang W, Ruan G, Liang M, Zheng J, Chen Y, et al. A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid Cancer. Int J Mol Sci. 2016;17: pubmed
    ..This can help to clarify the molecular mechanisms underlying PTC and offer potential biomarkers or therapeutic targets for future clinical practice. ..
  8. Teng L, Zheng Y, Wang H. BRCA1/2 associated hereditary breast cancer. J Zhejiang Univ Sci B. 2008;9:85-9 pubmed publisher
    ..But the outcome of BRCA1/2 associated hereditary breast cancers still remains controversial; further studies are needed to elucidate the nature of BRCA1/2 associated hereditary breast cancers. ..
  9. request reprint
    Yu Q, Yu X, Zhang S, Wang H, Wang H, Teng L. Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev. 2013;14:5735-40 pubmed
    ..93) and tumor recurrence (OR 1.81, 95% CI 1.21-2.71). We demonstrated that increased pretreatment serum CRP level (?10mg/L) was significantly associated with poor prognosis in gastric cancer patients, either in early or advanced stages. ..

More Information


  1. request reprint
    Chen X, Zhang H, Li Z, Yu X, Yang M, Wang H, et al. Indocyanine green clearance in evaluating the recovery of liver reserve function after superselective transarterial chemoembolization. Hepatobiliary Pancreat Dis Int. 2013;12:656-60 pubmed
    ..1% before TACE, P<0.01). Our data suggested that TACE decreased LRF, especially in older patients. ICG test was more sensitive to evaluate the recovery of LRF after TACE than the Child-Pugh grade and routine liver function tests. ..
  2. Yan D, Zhang W, Ke S, Zhao F, Yan S, Wang Q, et al. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma. BMC Cancer. 2017;17:678 pubmed publisher
    ..0004), LRFS (P = 0.0009), and DMFS (P < 0.0001), respectively. Pretreatment tumor ADC values supposed to be a noninvasive important prognostic parameter for NPC. ..
  3. Wang H, Lu J, Tang J, Chen S, He K, Jiang X, et al. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways. BMC Cancer. 2017;17:191 pubmed publisher
    ..These PDX GC models provide an ideal platform for drug screening and evaluation. GC patients with positive cMet or FGFR2 gene amplification may potentially benefit from cMet or FGFR2 targeted therapies or combined targeted therapy. ..